Pacific biosciences of california stock.

Raised approximately $201 million in gross proceeds in an upsized public offering of common stock in January 2023. ... Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve …

Pacific biosciences of california stock. Things To Know About Pacific biosciences of california stock.

Pacific Biosciences of California, Inc. Common Stock (PACB) 0 Add to Watchlist Add to Portfolio Quotes Summary Real-Time Key Data Bid Price and Ask Price The bid & ask …Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists ...Pacific Biosciences of California Inc’s ( PACB) price is currently up 16.83% so far this month. During the month of November, Pacific Biosciences of California Inc’s stock price has reached a high of $7.45 and a low of $5.74. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.55 and as low …Let’s take a look at how Pacific Biosciences of California Inc’s stock performed this quarter. Earnings: $-0.28 per share, versus the consensus estimate of $-0.32 per share, according to AAII’s Stock Investor Pro, Refinitiv and I/B/E/S. Revenue: $39 million, versus $33 million in the same period one year ago.As of September 25, 2023, 4:00 PM, CST, Pacific Biosciences of California Inc’s stock price was $8.46. Pacific Biosciences of California Inc is down 5.37% from its previous closing price of $8.94. During the last market session, Pacific Biosciences of California Inc’s stock traded between $8.88 and $9.11.

Pacific Biosciences of California Stock Performance. PACB stock opened at $8.88 on Friday. The business’s 50-day moving average price is $7.76 and its two-hundred day moving average price is $10.63.Apr 21, 2023 · Valuation for Pacific Biosciences In 2023, the firm anticipates generating revenues in the range of $165 million to $180 million, reflecting a 29% to 40% increase. During the fourth quarter, 76 ...

PacBio Announces Third Quarter 2023 Financial Results. MENLO PARK, Calif., Oct. 30, 2023 /PRNewswire/ — PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2023. Third quarter results Revenue of $55.7 million, a 72% increase…. Read more.

Pacific Biosciences of California Inc Stock , PACB 8.95 +0.07 +0.79% After-market 07:47:07 PM EDT 12/1/2023 NASPacific Biosciences of California has been profitable 1 over the past 10 years. Over the past twelve months, the company had a revenue of $146.10 million and Loss Per Share of $1.35.Currently, the analyst consensus on Pacific Biosciences is a Hold with an average price target of $11.40. See Insiders’ Hot Stocks on TipRanks >> The company has a one-year high of $14.20 and a ...Get Pacific Biosciences of California Inc (PACB.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsPacific Biosciences of California Inc’s Stock Price as of Market Close As of November 14, 2023, 4:00 PM, CST, Pacific Biosciences of California Inc’s stock price was $7.22. Pacific Biosciences of California Inc is up 12.11% from its previous closing price of $6.44.

Pacific Biosciences of California, Inc. Q4 Loss Increases, but beats estimates. (RTTNews) - Pacific Biosciences of California, Inc. (PACB) released Loss for its fourth quarter that increased from ...

Find out if Pacific Biosciences of California Inc (PACB:XNAS) stock is overpriced or undervalued based on Morningstar's evaluation. Assess the current comparison of market prices to the Fair Value ...

MENLO PARK, Calif., Jan. 24, 2023 /PRNewswire/ -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it intends to offer and sell $150.0 million of shares of its common stock in an underwritten public offering. PacBio also intends to grant the underwriters a 30-day option to purchase up to an additional $22.5 …Get the latest Pacific Biosciences of California, Inc. (PACB) stock news and headlines to help you in your trading and investing decisions. ... Pacific Biosciences of California, Inc. (NASDAQ:PACB ...Complete Pacific Biosciences of California Inc. stock information by Barron's. View real-time PACB stock price and news, along with industry-best analysis. Pacific Biosciences of California Inc’s price is currently up 27.53% so far this month. During the month of March, Pacific Biosciences of California Inc’s stock price has reached a high of $11.79 and a low of $8.01. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.20 and as low as $3.85.The stock of Pacific Biosciences of California (PACB 2.27%), a company developing DNA sequencing machines, is losing ground after an investor update. Preliminary fourth-quarter sales figures ...We note from Pacific Biosciences of California Inc’s average daily trading volume that its 10-day average is 4.96 million shares, with the 3-month average coming to 4.63 million. Pacific Biosciences of California Inc stock received a consensus recommendation rating of an Overweight, based on a mean score of 1.58.

Checking In on Pacific Biosciences to See If It's Still a Good 'Idea'...PACB Employees of TheStreet are prohibited from trading individual securities. These recently downgraded names are displaying both quantitative and technica...Transcript : Pacific Biosciences of California, Inc. Presents at UBS MedTech, Tools and Genomics Summit 2023, Aug-16-2023 04:00 PM Aug. 16: CI Pacific Biosciences of California, GeneDx Partner With University of Washington to Study Long-Read Sequencing Aug. 07: MTThese 9 analysts have an average price target of $11.22 versus the current price of Pacific Biosciences at $7.2, implying upside. Below is a summary of how these 9 analysts rated Pacific ...Find the latest Pacific Biosciences of California, Inc. (PACB) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.9.38M. AMZN. 146.74. +0.02%. 21.61M. View today's Pacific Biosciences of California stock price and latest PACB news and analysis. Create real-time notifications to follow any changes in the live ...Pacific Biosciences (PACB) Has Made a Bottom Pattern: Prices to Watch...PACB Pacific Biosciences of California Inc. (PACB) is a biotechnology company that develops and manufactures systems for gene sequencing and biological observation. Let...

Complete Pacific Biosciences of California Inc. stock information by Barron's. View real-time PACB stock price and news, along with industry-best analysis.Pacific Biosciences (PACB) Has Made a Bottom Pattern: Prices to Watch...PACB Pacific Biosciences of California Inc. (PACB) is a biotechnology company that develops and manufactures systems for gene sequencing and biological observation. Let...Pacific Biosciences of California Inc. PACB (U.S.: Nasdaq) Pacific Biosciences of California Inc. View All companies. REAL TIME 12:47 PM EST 11/30/23. $8.62 USD.Biotech stock Pacific Biosciences could return 50% in 12 months: TD Cowen. Pacific Biosciences of California Inc (NASDAQ: PACB) is trading meaningfully up on Friday after a TD Cowen analyst turned super bullish on the biotechnology company. Pacific Biosciences stock has upsi...According to 6 analyst offering 12-month price targets in the last 3 months, Pacific Biosciences has an average price target of $14.67 with a high of $17.00 and a low of $12.00. Below is a summary ...9.38M. AMZN. 146.74. +0.02%. 21.61M. View today's Pacific Biosciences of California stock price and latest PACB news and analysis. Create real-time notifications to follow any changes in the live ...

UBS Upgrades Pacific Biosciences of California to Buy From Neutral, Cuts Price Target to $10 From $13. Nov. 17. MT. Piper Sandler Trims Price Target on Pacific Biosciences of …

Pacific Biosciences (PACB) delivered earnings and revenue surprises of 23.53% and 17.95%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Pacific Biosciences of California's CEO is Christian O. Henry, appointed in Sep 2020, has a tenure of 3.17 years. total yearly compensation is $6.62M, comprised of 10.1% salary and 89.9% bonuses, including company stock and options. directly owns 0.088% of the company’s shares, worth $2.03M.Common Stock, par value $0.001 per share. PACB. ... Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. The Company has developed Single Molecule, …The notes will have a conversion price of $43.50 per share of the company's common stock, representing a 10% premium over Pacific Biosciences' share price as of the end of yesterday's trading session.Stock Quote. NASDAQ; PACB: Price; $8.88: Change; +0.4: Change(%); +4.72%: Volume; 4,099,397: 52 ... Pacific Biosciences of California, Inc. Third Quarter 2023 ...Nov 29, 2023 · See the latest Pacific Biosciences of California Inc stock price (PACB:XNAS), related news, valuation, dividends and more to help you make your investing decisions. April 11, 2023 at 12:00 PM · 4 min read. Pacific Biosciences of California (PACB) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in ...Dec 1, 2023 · The Pacific Biosciences of California stock price gained 4.72% on the last trading day (Friday, 1st Dec 2023), rising from $8.48 to $8.88. During the last trading day the stock fluctuated 8.77% from a day low at $8.21 to a day high of $8.93. The price has risen in 7 of the last 10 days and is up by 17% over the past 2 weeks. Transcript : Pacific Biosciences of California, Inc. Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-12-2023 12:55 PM Sep. 12: CI Pacific Biosciences of California Introduces Program for Customers to Lease its Sequencing Systems Sep. 12: MTStock analysis for Pacific Biosciences of California Inc (PACB:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Pacific Biosciences of California Inc’s Stock Price as of Market Close As of November 17, 2023, 4:00 PM, CST, Pacific Biosciences of California Inc’s stock price was $8.40. Pacific Biosciences of California Inc is up 10.67% from its previous closing price of $7.59.Pacific Biosciences of California Inc. published this content on 15 November 2022 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 15 November 2022 20:01:02 UTC .

Shares of Pacific Biosciences of California Inc. tumbled 3% in morning trading the day after the Federal Trade Commission announced plans to challenge Illumina Inc.'s plans …The Pacific Biosciences of California stock price gained 4.72% on the last trading day (Friday, 1st Dec 2023), rising from $8.48 to $8.88. During the last trading day the stock fluctuated 8.77% from a day low at $8.21 to a day high of $8.93. The price has risen in 7 of the last 10 days and is up by 17% over the past 2 weeks.The current consensus among the 12 polled investment analysts is to buy stock in Pacific Biosciences of California Inc. PACB reported earnings per share of -$0.30 for the current quarter and $53.0 million in sales for the same period. However, it is important to note that the financial data provided is as of February 14 and may not be the …Instagram:https://instagram. drive for tysontop mortgage lenders in ohiobest online cs degreeoil future contract prices Valuation for Pacific Biosciences In 2023, the firm anticipates generating revenues in the range of $165 million to $180 million, reflecting a 29% to 40% increase. During the fourth quarter, 76 ... lincoln bicentennial penniesnon traded reit list Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems.Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists ... trading spy options Within the last quarter, Pacific Biosciences (NASDAQ:PACB) has observed the following analyst ratings: These 9 analysts have an average price target of $11.22 versus the current price of Pacific ...Pacific Biosciences of California, Inc. has a twelve month low of $5.74 and a twelve month high of $14.55. The stock has a market cap of $2.37 billion, a P/E ratio of -6.99 and a beta of 1.78. The ...